Pura Vida Investments, LLC
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 12, 2026), Pura Vida Investments, LLC reported 17 stock positions worth $14.9 million. Its top holding was Insight Molecular Diagnostic (IMDX) at 20.9% of the portfolio, followed by Beta Bionics (BBNX, 18.9%) and Establishment Labs (ESTA, 17.2%). Compared with Q4 2025, it sold out of 1, added to 3 and reduced 1. The biggest buy was Nvidia (NVDA, shares +7%) and the biggest sale an exit from Danaher (DHR).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001590144
- Portfolio Value
- $14.9M (Q1 2026)
- SEC Filing
- 0001590144-26-000003 ↗ filed May 12, 2026
Holdings Value
Holdings 17 stocks · $14.9M
| IMDX Insight Molecular Diagnostic | 20.88% | 947,134 | $3.1M | No change |
| BBNX Beta Bionics Inc. | 18.94% | 281,250 | $2.8M | No change |
| ESTA Establishment Labs Holdings | 17.17% | 45,000 | $2.6M | No change |
| CAI Caris Life Sciences Inc. | 10.81% | 89,940 | $1.6M | No change |
| NSPR Inspiremd Inc. | 4.94% | 450,517 | $734K | No change |
| NTRA Natera Inc. | 3.36% | 2,500 | $500K | No change |
| NVDA Nvidia Corp. | 2.93% | 2,500 | $436K | Add +7.3% |
| JPM JPMorgan Chase & Co. | 2.67% | 1,350 | $397K | No change |
| MSFT Microsoft Corp. | 2.46% | 990 | $366K | Reduce -17.5% |
| MGX Metagenomi Therapeutics Inc. | 2.38% | 264,391 | $354K | No change |
| GOOG Alphabet Inc. Class C | 2.29% | 1,190 | $341K | No change |
| OM Outset Medical Inc. | 2.15% | 83,333 | $320K | Add +1566.7% |
| ADI Analog Devices Inc. | 2.14% | 1,000 | $318K | No change |
| AAPL Apple Inc. | 1.99% | 1,165 | $296K | No change |
| ASML ASML Holding NV-NY Reg SHS filed as ASML HLDG NV | 1.69% | 190 | $251K | No change |
| LIN Linde PLC | 1.67% | 500 | $248K | No change |
| AMZN Amazon.com Inc. | 1.54% | 1,100 | $229K | Add +10.0% |
Portfolio Sells Q4 2025 → Q1 2026
Portfolio Buys Q4 2025 → Q1 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 19 | $37.0M | ALMR, BBNX, ESTA, IMDX, NVDA |
| Q1 2026 | 17 | $14.9M | IMDX, BBNX, ESTA, CAI, NSPR |
| Q4 2025 | 18 | $26.8M | BBNX, IMDX, ESTA, CAI, NSPR |
| Q3 2025 | 8 | $16.4M | BBNX, IMDX, CAI, ESTA, NSPR |
| Q2 2025 | 8 | $16.6M | BBNX, IMDX, CAI, ESTA, OM |
| Q1 2025 | 8 | $13.7M | BBNX, IMDX, ESTA, NSPR, KMTS |
| Q4 2024 | 9 | $18.1M | ESTA, MSOS, LUNG, QTRX, IMDX |
| Q3 2024 | 16 | $60.8M | MSOS, ESTA, GKOS, NTRA, ISRG |
| Q2 2024 | 25 | $82.7M | ESTA, GKOS, ISRG, NTRA, MSOS |
| Q1 2024 | 30 | $146.8M | EXAS, ESTA, ISRG, QTRX, LYRA |